Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $6.7600 (5.96%) ($6.2500 - $6.7800) on Mon. Mar. 11, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.79% (three month average) | RSI | 75 | Latest Price | $6.7600(5.96%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -0.2% a day on average for past five trading days. | Weekly Trend | TGTX advances 13.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(65%) ARKG(58%) IBB(58%) ARKK(57%) IWO(57%) | Factors Impacting TGTX price | TGTX will decline at least -2.895% in a week (0% probabilities). VXX(-17%) UUP(-12%) TLT(-9%) VIXM(-8%) FIVG(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.895% (StdDev 5.79%) | Hourly BBV | 0 () | Intraday Trend | 4.8% | | | |
|
5 Day Moving Average | $6.4(5.62%) | 10 Day Moving Average | $6.32(6.96%) | 20 Day Moving Average | $5.55(21.8%) | To recent high | -6.2% | To recent low | 35.2% | Market Cap | $856m | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |